Access cutting-edge gaucher disease treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access gaucher disease specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gaucher disease treatment provided free
The purpose of this study is to measure levels of blood and brain chemicals related to oxidative stress and inflammation in healthy volunteers and individuals with Type 1 Gaucher disease (GD1) to see if these levels are altered by GD1.
Sponsor: University of Minnesota
Check if you qualify for this gaucher disease clinical trial in New York, NY
If you're searching for gaucher disease treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gaucher disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.